Enzon Pharmaceuticals, Inc. (BST:EZ1)
0.0555
0.00 (0.00%)
At close: Oct 16, 2025
Enzon Pharmaceuticals Revenue
In the year 2024, Enzon Pharmaceuticals had annual revenue of $26 thousand USD.
Revenue
$26.00K
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
$26.00K
Employees
1
Market Cap
4.71M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 26.00K | - | - |
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | 26.00K | -675.00K | -96.29% |
Dec 31, 2021 | 701.00K | 649.00K | 1,248.08% |
Dec 31, 2020 | 52.00K | -155.00K | -74.88% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Mercedes-Benz Group AG | 139.36B |
Bayerische Motoren Werke Aktiengesellschaft | 136.51B |
Deutsche Telekom AG | 120.55B |
Allianz SE | 109.02B |
Siemens Aktiengesellschaft | 78.30B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
Siemens Energy AG | 38.39B |
SAP SE | 35.89B |